Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Lymphoma, Chronic Lymphocytic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00735930
What this trial is testing

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
AnemiaChronic Lymphocytic LeukemiaProlymphocytic Leukemia+3 more
National Cancer Institute (NCI) 39
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Study completedNCT00968760
What this trial is testing

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

Who this might be right for
LymphomaB-cell Lymphoma
M.D. Anderson Cancer Center 34
Large-scale testing (Phase 3)UnknownNCT02186574
What this trial is testing

Tenofovir to Prevent HBV Reactivation

Who this might be right for
Hepatitis BLymphomaNon-Hodgkin
University Health Network, Toronto 184
Early research (Phase 1)Study completedNCT00058396
What this trial is testing

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Early research (Phase 1)Study completedNCT00694590
What this trial is testing

Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
Genzyme, a Sanofi Company 24
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Study completedNCT01002755
What this trial is testing

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaFatigueFever+7 more
M.D. Anderson Cancer Center 36
Early research (Phase 1)Ended earlyNCT00907517
What this trial is testing

Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247)

Who this might be right for
Myelogenous Leukemia, AcuteLeukemia, Lymphocytic, AcuteLeukemia, Lymphoblastic, Acute, Philadelphia-Positive+1 more
Merck Sharp & Dohme LLC 24
Testing effectiveness (Phase 2)Study completedNCT00132015
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
National Institutes of Health Clinical Center (CC) 37
Not applicableLooking for participantsNCT05371808
What this trial is testing

Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Canadian Cancer Trials Group 247
Testing effectiveness (Phase 2)UnknownNCT02851589
What this trial is testing

Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT01419691
What this trial is testing

Phase I and II Study of Auranofin in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic LymphomaLeukemia, Prolymphocytic
University of Kansas Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT02315118
What this trial is testing

Pilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell Malignancies

Who this might be right for
B-Cell Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma
National University Hospital, Singapore 18
Early research (Phase 1)Ended earlyNCT00643240
What this trial is testing

Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota 1
Testing effectiveness (Phase 2)Study completedNCT00603668
What this trial is testing

Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL

Who this might be right for
Chronic Lymphocytic Lymphoma
Gilead Sciences 19
Testing effectiveness (Phase 2)Study completedNCT02639910
What this trial is testing

Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
MorphoSys AG 24
Early research (Phase 1)Looking for participantsNCT04545762
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Refractory Non-Hodgkin LymphomaBurkitt LymphomaMantle Cell Lymphoma+7 more
C. Babis Andreadis 36
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Next Page